Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: The impact of medication reviews by general practitioners on psychotropic drug use and behavioral and psychological symptoms in home-dwelling people with dementia: results from the multicomponent cluster randomized controlled LIVE@Home.Path trial

Fig. 1

The stepped-wedge closed-cohort randomized controlled LIVE@Home.Path trial during the COVID-19 pandemic. The COVID-19 pandemic temporarily halted the trial protocol at 6 months. This substudy includes all dyads (people with dementia and informal caregivers) who completed the first 6-month period, solely analyzing prepandemic data. In this first 6-month period, dyads randomized to Group 1 received the LIVE (Learning, Innovation, Volunteer support, and Empowerment) intervention while dyads randomized to Group 2 and Group 3 served as controls receiving health care as usual

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us